Archiv der Pharmazie

Papers
(The median citation count of Archiv der Pharmazie is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors139
1,2,3‐Triazole hybrids as anticancer agents: A review102
Coumarin‐containing hybrids and their antibacterial activities67
Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors65
Coumarin derivatives with anticancer activities: An update63
Sulfonamides incorporating ketene N,S‐acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors61
1,2,3‐Triazole hybrids with anti‐HIV‐1 activity61
Determination of the inhibition profiles of pyrazolyl–thiazole derivatives against aldose reductase and α‐glycosidase and molecular docking studies57
Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3‐diaryltriazene‐substituted sulfathiazole derivatives57
Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds55
Synthesis, characterization, molecular docking, and biological activities of coumarin–1,2,3‐triazole‐acetamide hybrid derivatives50
1,3,5‐Triazine: A versatile pharmacophore with diverse biological activities48
Recent advances with alkaline phosphatase isoenzymes and their inhibitors46
Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors45
Aromatase inhibitors: Role in postmenopausal breast cancer43
Pharmacophore‐linked pyrazolo[3,4‐d]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies43
Synthesis and antidiabetic evaluation of benzimidazole‐tethered 1,2,3‐triazoles42
Design, synthesis, and biological activity of novel dithiocarbamate‐methylsulfonyl hybrids as carbonic anhydrase inhibitors40
Novel 2‐cyanoacrylamido‐4,5,6,7‐tetrahydrobenzo[b]thiophene derivatives as potent anticancer agents38
Design, synthesis, molecular docking, and anticancer evaluations of 1‐benzylquinazoline‐2,4(1H,3H)‐dione bearing different moieties as VEGFR‐2 inhibitors36
Recent update on antibacterial and antifungal activity of quinoline scaffolds36
Pyrazole–coumarin and pyrazole–quinoline chalcones as potential antitubercular agents35
Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms34
Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations34
5‐(4‐Methoxybenzylidene)thiazolidine‐2,4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations33
Design, synthesis, molecular modeling, and antimicrobial potential of novel 3‐[(1H‐pyrazol‐3‐yl)imino]indolin‐2‐one derivatives as DNA gyrase inhibitors33
Natural indole‐containing alkaloids and their antibacterial activities32
Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone‐based benzenesulfonamides31
Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2,4‐dichloro)benzylidene]thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibit31
Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives30
In vitro and in silico studies of fluorinated 2,3‐disubstituted thiazolidinone‐pyrazoles as potential α‐amylase inhibitors and antioxidant agents30
New 1,2,3‐triazole–(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation29
Pyridine‐derived VEGFR‐2 inhibitors: Rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking28
Ecofriendly synthesis of pyrano[2,3‐d]pyrimidine derivatives and related heterocycles with anti‐inflammatory activities27
In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors27
Quinoline‐based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors27
Synthesis of N‐alkylated pyrazolo[3,4‐d]pyrimidine analogs and evaluation of acetylcholinesterase and carbonic anhydrase inhibition properties26
Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives25
Synthesis and in silico studies of triazene‐substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors25
Oxadiazole: A highly versatile scaffold in drug discovery25
Synthesis and biological evaluation of some 1‐naphthol derivatives as antioxidants, acetylcholinesterase, and carbonic anhydrase inhibitors25
Anticancer activity of novel 3‐(furan‐2‐yl)pyrazolyl and 3‐(thiophen‐2‐yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies24
Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors24
Synthesis of benzamide derivatives with thiourea‐substituted benzenesulfonamides as carbonic anhydrase inhibitors24
Novel pyrazole‐clubbed thiophene derivatives via Gewald synthesis as antibacterial and anti‐inflammatory agents24
N‐Substituted‐4‐phenylphthalazin‐1‐amine‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studies24
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase23
Novel 1,2,4‐triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies23
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development22
Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea22
Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease21
Azetidines of pharmacological interest21
Indole/isatin‐containing hybrids as potential antibacterial agents21
Synthesis and docking study of benzimidazole–triazolothiadiazine hybrids as aromatase inhibitors21
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation21
Cinnamic acid hybrids as anticancer agents: A mini‐review21
New thiazolyl‐pyrazoline derivatives bearing nitrogen mustard as potential antimicrobial and antiprotozoal agents21
Recent progress of 1,3,4‐oxadiazoles as anticonvulsants: Future horizons21
Design and synthesis of pyrazole–pyrazoline hybrids as cancer‐associated selective COX‐2 inhibitors20
Cytotoxic and antimicrobial potential of benzimidazole derivatives20
Synthesis, characterization, and biological evaluation of some novel Schiff bases as potential metabolic enzyme inhibitors19
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds19
(+)‐Camphor and (−)‐borneol derivatives as potential anti‐orthopoxvirus agents19
Novel benzo[b]xanthene derivatives: Bismuth(III) triflate‐catalyzed one‐pot synthesis, characterization, and acetylcholinesterase, glutathione S‐transferase, and butyrylcholinesterase inhibitor19
Synthesis of novel sulfonamides with anti‐Alzheimer and antioxidant capacities19
Biscoumarin–pyrimidine conjugates as potent anticancer agents and binding mechanism of hit candidate with human serum albumin19
Design, synthesis, and biological evaluation of novel morpholinated isatin–quinoline hybrids as potent anti‐breast cancer agents18
Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones18
Discovery of novel furo[2,3‐d]pyrimidin‐2‐one–1,3,4‐oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis18
Ginkgo biloba in the management of the COVID‐19 severity17
Advances in 2‐substituted benzothiazole scaffold‐based chemotherapeutic agents17
Design, synthesis, and biological evaluation of isatin‐indole‐3‐carboxaldehyde hybrids as a new class of xanthine oxidase inhibitors17
Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety17
Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX‐2/5‐LOX inhibitors17
Anticancer activity of bisindole alkaloids derived from natural sources and synthetic bisindole hybrids17
1,2,4‐Triazole hybrids with potential antibacterial activity against methicillin‐resistant Staphylococcus aureus17
Design, synthesis, and biological evaluation of imidazopyridine‐linked thiazolidinone as potential anticancer agents16
1,2,3‐Triazole‐linked 5‐benzylidene (thio)barbiturates as novel tyrosinase inhibitors and free‐radical scavengers16
In silico molecular docking studies of oxadiazole and pyrimidine bearing heterocyclic compounds as potential antimicrobial agents15
Phyllobilins as a challenging diverse natural product class: Exploration of pharmacological activities15
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects15
(E)‐2‐(2‐Allylidenehydrazinyl)thiazole derivatives: Design, green synthesis, in silico and in vitro antimycobacterial and radical scavenging studies15
Structure–activity relationship studies of indolin‐2‐one derivatives as vascular endothelial growth factor receptor inhibitors and anticancer agents15
The antimalarial activity of indole alkaloids and hybrids15
Thieno[2,3‐b]pyridine amines: Synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer's disease15
Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021)15
Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR‐γ agonists and thymidylate synthase inhibitors14
Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors14
Development of novel indole‐linked pyrazoles as anticonvulsant agents: A molecular hybridization approach14
Evaluation of the antiparasitic activities of imidazol‐2‐ylidene–gold(I) complexes14
Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies14
Reprogramming of antibiotics to combat antimicrobial resistance14
The anticancer activity of carbazole alkaloids14
Synthesis, characterization, crystal structure, α‐glycosidase, and acetylcholinesterase inhibitory properties of 1,3‐disubstituted benzimidazolium salts14
Chemical composition and antimicrobial activity of Osage orange (Maclura pomifera) leaf extracts13
Synthesis and docking calculations of tetrafluoronaphthalene derivatives and their inhibition profiles against some metabolic enzymes13
New N‐phenylacetamide‐linked 1,2,3‐triazole‐tethered coumarin conjugates: Synthesis, bioevaluation, and molecular docking study13
Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3,5‐dimethoxy benzaldehyde motif13
Thiophene‐containing compounds with antimicrobial activity13
New indomethacin analogs as selective COX‐2 inhibitors: Synthesis, COX‐1/2 inhibitory activity, anti‐inflammatory, ulcerogenicity, histopathological, and docking studies13
Synthesis and anticancer properties of novel hydrazone derivatives incorporating pyridine and isatin moieties13
PXR–ABC drug transporters/CYP‐mediated ursolic acid transport and metabolism in vitro and vivo13
Investigation of HMG‐CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives12
Synthesis and anticancer activity of ethyl 5‐amino‐1‐N‐substituted‐imidazole‐4‐carboxylate building blocks12
Synthesis, anti‐inflammatory activity, and molecular docking studies of some novel Mannich bases of the 1,3,4‐oxadiazole‐2(3H)‐thione scaffold12
Pharmacological report of recently designed multifunctional coumarin and coumarin–heterocycle derivatives12
Effect of substituents in the A and B rings of chalcones on antiparasite activity12
New quinoxalin‐1,3,4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies12
Resveratrol isoforms and conjugates: A review from biosynthesis in plants to elimination from the human body12
N‐Substituted pyrimidinethione and acetophenone derivatives as a new therapeutic approach in diabetes12
Synthesis and biological evaluation of resveratrol derivatives with anti‐breast cancer activity12
Silver–N‐heterocyclic carbene complexes‐catalyzed multicomponent reactions: Synthesis, spectroscopic characterization, density functional theory calculations, and antibacterial study12
The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers11
Novel N‐benzylpiperidine derivatives of 5‐arylisoxazole‐3‐carboxamides as anti‐Alzheimer's agents11
Exploration of thiazolidine‐2,4‐diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations11
Catechol‐bearing imidazolium and benzimidazolium chlorides as promising antimicrobial agents11
Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine‐1,1‐dioxide derivatives11
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers11
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles11
Methylene‐bearing sulfur‐containing cyanopyrimidine derivatives for treatment of cancer: Part‐II11
Novel benzenesulfonamide‐bearing pyrazoles and 1,2,4‐thiadiazoles as selective carbonic anhydrase inhibitors11
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models11
Synthesis and antimicrobial evaluation of new nitric oxide‐donating fluoroquinolone/oxime hybrids11
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes11
Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation10
Facile synthesis of C6‐substituted benz[4,5]imidazo[1,2‐a]quinoxaline derivatives and their anticancer evaluation10
Design, synthesis, and molecular docking study of new monastrol analogues as kinesin spindle protein inhibitors10
3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde dehydrogenase 1A1 inhibito10
Discovery of 2,4‐diaminopyrimidine derivatives targeting p21‐activated kinase 4: Biological evaluation and docking studies10
Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study10
Synthesis and biological evaluation of substituted pyrrolidines and pyrroles as potential anticancer agents9
Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives9
Comparison of extraction efficiency and selectivity between low‐temperature pressurized microwave‐assisted extraction and prolonged maceration9
Synthesis and radioligand‐binding assay of 2,5‐disubstituted thiadiazoles and evaluation of their anticonvulsant activities9
Synthesis and antimalarial and anticancer evaluation of 7‐chlorquinoline‐4‐thiazoleacetic derivatives containing aryl hydrazide moieties9
Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin–1,2,4‐triazole scaffolds9
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors9
Probing simple structural modification of α‐mangostin on its cholinesterase inhibition and cytotoxicity9
Evaluation of isoindole derivatives: Antioxidant potential and cytotoxicity in the HT‐29 colon cancer cells9
Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies9
Design, synthesis, and cytotoxicity screening of new synthesized imidazolidine‐2‐thiones as VEGFR‐2 enzyme inhibitors9
Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR‐2 inhibitors9
3′‐Methyl‐4‐thio‐1H‐tetrahydropyranspiro‐5′‐hydantoin platinum complex as a novel potent anticancer agent and xanthine oxidase inhibitor9
Simultaneous analysis of oxytetracycline hydrochloride, lidocaine, and bromhexine hydrochloride in the presence of many interfering excipients9
Design, synthesis, and α‐glucosidase‐inhibitory activity of phenoxy‐biscoumarin–N‐phenylacetamide hybrids9
Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors8
Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3‐c]quinazolines as classical DNA intercalators8
Synthesis of novel 4,5‐dihydropyrrolo[1,2‐a]quinoxalines, pyrrolo[1,2‐a]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity8
Synthesis, cytotoxicity, and molecular docking of substituted 3‐(2‐methylbenzofuran‐3‐yl)‐5‐(phenoxymethyl)‐1,2,4‐oxadiazoles8
Bioevaluation of synthetic pyridones as dual inhibitors of α‐amylase and α‐glucosidase enzymes and potential antioxidants8
Design, synthesis, and molecular docking study of novel quinoline‐based bis‐chalcones as potential antitumor agents8
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐198
Synthesis and evaluation of novel xanthene‐based thiazoles as potential antidiabetic agents8
Potential targeting of Hep3B liver cancer cells by lupeol isolated from Avicennia marina8
Upregulation of BAX and caspase‐3, as well as downregulation of Bcl‐2 during treatment with indeno[1,2‐b]quinoxalin derivatives, mediated apoptosis in human cancer cells8
Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX‐2 inhibitors8
Novel promising benzoxazole/benzothiazole‐derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis8
Systematic response of staurosporine scaffold‐based inhibitors to drug‐resistant cancer kinase mutations8
Cyanopropyl functionalized benzimidazolium salts and their silver N‐heterocyclic carbene complexes: Synthesis, antimicrobial activity, and theoretical analysis8
Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents8
Binding of boswellic acids to functional proteins of the SARS‐CoV‐2 virus: Bioinformatic studies8
Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease8
In silico studies, nitric oxide, and cholinesterases inhibition activities of pyrazole and pyrazoline analogs of diarylpentanoids8
A new series of hydrazones as small‐molecule aldose reductase inhibitors8
Antitumor and multikinase inhibition activities of some synthesized coumarin and benzofuran derivatives8
New nanodrug design for cancer therapy: Its synthesis, formulation, in vitro and in silico evaluations7
Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies7
Bioevaluation of quinoline‐4‐carbonyl derivatives of piperazinyl‐benzothiazinones as promising antimycobacterial agents7
Synthesis and antitumor potential of new arylidene ursolic acid derivatives via caspase‐8 activation7
Molecular hydrogen (H2) as a potential treatment for acute and chronic fatigue7
Influence of the pKa value on the antioxidant activity of licorice flavonoids under solvent‐mediated effects7
Synthesis and biological evaluation of coumarin‐thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors7
Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluations7
Synthesis and biological evaluation of Val–Val dipeptide–sulfonamide conjugates7
Synthesis and biological evaluation of novel isoxazole derivatives from acridone7
Synthesis of new arylazopyrazoles as apoptosis inducers: Candidates to inhibit proliferation of MCF‐7 cells7
Synthesis of new 7‐amino‐3,4‐dihydroquinolin‐2(1H)‐one‐peptide derivatives and their carbonic anhydrase enzyme inhibition, antioxidant, and cytotoxic activities7
A new series of benzoxazole‐based SIRT1 modulators for targeted therapy of non‐small‐cell lung cancer7
Zinc(II) complexation strategy for ultra‐sensitive fluorimetric estimation of molnupiravir: Applications and greenness evaluation7
1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities7
New halogenated chalcones with cytotoxic and carbonic anhydrase inhibitory properties: 6‐(3‐Halogenated phenyl‐2‐propen‐1‐oyl)‐2(3H)‐benzoxazolones7
Synthesis and antimicrobial activity of new 2‐piperazin‐1‐yl‐N‐1,3‐thiazol‐2‐ylacetamides of cyclopenta[c]pyridines and pyrano[3,4‐c]pyridines7
Design, synthesis, and antiproliferative effect of 2,9‐bis[4‐(pyridinylalkylaminomethyl)phenyl]‐1,10‐phenanthroline derivatives on human leukemic cells by targeting G‐quadruplex7
Antiprotozoal agents: How have they changed over a decade?7
Insights into the chemistry and therapeutic potential of acrylonitrile derivatives7
Design and synthesis of benzenesulfonamide‐linked imidazo[2,1‐b][1,3,4]thiadiazole derivatives as carbonic anhydrase I and II inhibitors7
Development of new Alzheimer's disease drug candidates using donepezil as a key model7
Structure‐based design, synthesis, and evaluation of Bcl‐2/Mcl‐1 dual inhibitors7
Synthesis, docking studies, and pharmacological evaluation of 2‐hydroxypropyl‐4‐arylpiperazine derivatives as serotoninergic ligands7
Current perspectives on naturally occurring saponins as anticancer agents7
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors7
Recent advances in indole dimers and hybrids with antibacterial activity against methicillin‐resistant Staphylococcus aureus7
Eugenol carbonate activity against Plasmodium falciparum, Leishmania braziliensis, and Trypanosoma cruzi7
Piperazine and piperidine‐substituted 7‐hydroxy coumarins for the development of anti‐inflammatory agents7
Hybridization‐based design of novel anticholinesterase indanone–carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies7
Drug re‐engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery7
Design and synthesis of new lenalidomide analogs via Suzuki cross‐coupling reaction7
Design, synthesis, evaluation, and molecular modeling studies of indolyl oxoacetamides as potential pancreatic lipase inhibitors7
Novel 2‐substituted thioquinazoline‐benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity7
Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment7
Design, synthesis, and in silico studies of tetrahydropyrimidine analogs as urease enzyme inhibitors7
Design, synthesis, biological evaluation, and in silico studies of 2‐aminobenzothiazole derivatives as potent PI3Kα inhibitors7
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands7
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia‐derived cells: Role of PKCβ7
The antimalarial activity of 1,2,4‐trioxolane/trioxane hybrids and dimers: A review6
Amoebicidal effect of 5,5′‐[(4‐nitrophenyl)methylene]bis‐6‐hydroxy‐2‐mercapto‐3‐methyl‐4(3H)‐pyrimidinone), a new drug against Entamoeba histolytica6
New pyrimidine/thiazole hybrids endowed with analgesic, anti‐inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX‐2/sEH dual inhibition6
Fintiamin: A diketopiperazine from the marine sponge‐derived fungus Eurotium sp.6
Synthesis, antiproliferative activities, and DNA binding of coumarin‐3‐formamido derivatives6
Design, synthesis, anticancer, and docking of some S‐ and/or N‐heterocyclic derivatives as VEGFR‐2 inhibitors6
Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase6
New PEPPSI‐Pd‐NHC complexes bearing 4‐hydroxyphenylethyl group: Synthesis, characterization, molecular docking, and bioactivity properties6
Design, synthesis, in silico, and in vitro evaluation of 3‐phenylpyrazole acetamide derivatives as antimycobacterial agents6
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties6
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluatio6
Novel substituted 5‐methyl‐4‐acylaminoisoxazoles as antimitotic agents: Evaluation of selectivity to LNCaP cancer cells6
Concise syntheses and some biological activities of dl‐2,5‐di‐O‐methyl‐chiro‐inositol, dl‐1,4‐di‐O‐methyl‐scyllo‐inositol, and dl‐1,6‐dibro6
Synthesis, structural characterization, and biological studies of ATBS–M complexes (M(II) = Cu, Co, Ni, and Mn): Access for promising antibiotics and anticancer agents6
Developing a scaffold for urease inhibition based on benzothiazoles: Synthesis, docking analysis, and therapeutic potential6
Design, synthesis, and biological evaluation of 1,2,4‐oxadiazole‐containing pyrazolo[3,4‐b]pyridinones as a new series of AMPKɑ1β1γ1 activators6
Development, synthesis, and biological evaluation of sulfonyl‐α‐l‐amino acids as potential anti‐Helicobacter pylori and IMPDH inhibitors6
Investigation of tyrosinase enzyme (from mushroom) inhibitory activities and antioxidant properties of new fluorine‐containing phthalocyanines6
Synthesis of new 1,2,4‐triazole–(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis6
Design and development of novel series of indole‐3‐sulfonamide ureido derivatives as selective carbonic anhydrase II inhibitors6
New 3‐(1H‐benzo[d]imidazol‐2‐yl)quinolin‐2(1H)‐one‐based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis‐inducing agents6
Garcinol from Garcinia indica inhibits HIV‐1 reverse transcriptase‐associated ribonuclease H6
Substituted adamantylphthalimides: Synthesis, antiviral and antiproliferative activity6
Antiretroviral and cytotoxic activities of Tityus obscurus synthetic peptide6
Anti‐inflammatory activity of pyridazinones: A review6
Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor6
Design and synthesis of novel quinazolinone‐based fibrates as PPARα agonists with antihyperlipidemic activity6
Prevalence of nitrosamine contaminants in drug samples: Has the crisis been overcome?5
5‐Arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones with selective inhibitory activity against some leukemia cell lines5
Pyrazole/pyrazoline as an excellent pharmacophore in the design of carbonic anhydrase inhibitors (2018–2022)5
Multitarget‐directed therapeutics: (Urea/thiourea)2 derivatives of diverse heterocyclic‐Lys conjugates5
A novel class for carbonic anhydrases inhibitors and evaluation of their non‐zinc binding5
Effective chiral pool synthesis of both enantiomers of the TRPML inhibitor trans‐ML‐SI35
Novel indole hydrazide derivatives: Synthesis and their antiproliferative activities through inducing apoptosis and DNA damage5
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review5
Flucytosine‐based prodrug activation by cold physical plasma5
Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4‐b]pyridines with potential p38α MAPK‐inhibitory activity5
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis5
The C‐terminally shortened analogs of a hexapeptide derived from Lingzhi hydrolysate with enhanced tyrosinase‐inhibitory activity5
Microwave‐assisted N‐alkylation of amines with alcohols catalyzed by MnCl2: Anticancer, docking, and DFT studies5
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action5
Phytochemical characterization and effects on cell proliferation of Pinus nigra Arn. bark5
New 1,3,4‐oxadiazole‐chalcone/benzimidazole hybrids as potent antiproliferative agents5
Comparative analysis of apocarotenoids and phenolic constituents of Crocus sativus stigmas from 11 countries: Ecological impact5
Natural cyclic polypeptides as vital phytochemical constituents from seeds of selected medicinal plants5
Design, synthesis, and molecular docking of novel 3,5‐disubstituted‐1,3,4‐oxadiazole derivatives as iNOS inhibitors5
0.077996015548706